BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2068472)

  • 1. Aztreonam plus clindamycin versus tobramycin plus clindamycin in the treatment of intraabdominal infections.
    Williams RR; Hotchkin D
    Rev Infect Dis; 1991; 13 Suppl 7():S629-33. PubMed ID: 2068472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of aztreonam plus clindamycin with tobramycin plus clindamycin in the treatment of intra-abdominal infections.
    Birolini D; Moraes MF; de Souza OS
    Chemotherapy; 1989; 35 Suppl 1():49-57. PubMed ID: 2659290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aztreonam plus clindamycin vs. tobramycin plus clindamycin for the treatment of intraabdominal infections.
    Birolini D; Moraes MF; de Souza OS
    Rev Infect Dis; 1985; 7 Suppl 4():S724-8. PubMed ID: 3909330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clindamycin plus amikacin versus clindamycin plus aztreonam in established intraabdominal infections.
    Barboza E; del Castillo M; Yi A; Gotuzzo E
    Surgery; 1994 Jul; 116(1):28-35. PubMed ID: 8023265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overall clinical experience with aztreonam in the treatment of intraabdominal infections.
    Henry SA
    Rev Infect Dis; 1985; 7 Suppl 4():S729-33. PubMed ID: 3909331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
    Rivera-Vazquez CR; Ramirez-Ronda CH; Rodriguez JR; Saavedra S
    Chemotherapy; 1989; 35 Suppl 1():89-100. PubMed ID: 2659296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meropenem versus tobramycin plus clindamycin for treatment of intraabdominal infections: results of a prospective, randomized, double-blind clinical trial.
    Condon RE; Walker AP; Sirinek KR; White PW; Fabian TC; Nichols RL; Wilson SE
    Clin Infect Dis; 1995 Sep; 21(3):544-50. PubMed ID: 8527541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections.
    de Groot HG; Hustinx PA; Lampe AS; Oosterwijk WM
    J Antimicrob Chemother; 1993 Sep; 32(3):491-500. PubMed ID: 8262872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of aztreonam-clindamycin versus tobramycin-clindamycin in the treatment of lower respiratory tract infections caused by aerobic gram-negative bacilli.
    Rodríguez JR; Ramírez-Ronda CH; Nevárez M
    Antimicrob Agents Chemother; 1985 Feb; 27(2):246-51. PubMed ID: 4039118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
    Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
    Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of aztreonam and tobramycin in the treatment of lower respiratory tract infections caused by gram-negative bacilli.
    Nolen TM; Phillips HL; Hall HJ
    Rev Infect Dis; 1985; 7 Suppl 4():S666-8. PubMed ID: 3909321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a randomized, multicenter trial of meropenem versus clindamycin/tobramycin for the treatment of intra-abdominal infections.
    Wilson SE
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S197-206. PubMed ID: 9126694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infections in patients in intensive care units: can the combination of a monobactam and a penicillin replace the classic combination of a beta-lactam agent and an aminoglycoside?
    Colardyn F; Gala JL; Verschraegen G; Wauters G; Vogelaers D; Dive A; Claeys G; Magis A; Vandercam B; Mahieu P
    Rev Infect Dis; 1991; 13 Suppl 7():S640-4. PubMed ID: 2068474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overall clinical experience with aztreonam in the treatment of obstetric-gynecologic infections.
    Henry SA
    Rev Infect Dis; 1985; 7 Suppl 4():S703-8. PubMed ID: 3909327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftazidime/clindamycin versus tobramycin/clindamycin in the treatment of intra-abdominal infections.
    Bubrick MP; Heim-Duthoy KL; Yellin AE; Berne TV; Heseltine PN; Appleman MD; Cocchetto DM; Matzke GR
    Am Surg; 1990 Oct; 56(10):613-7. PubMed ID: 2221611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bacterial infections in cancer patients without neutropenia. Comparison between 2 antibiotic combinations (aztreonam and oxacillin versus cefoxitin and tobramycin)].
    Apice G; Beneduce G; Bruni GS; D'Aprile M; Perna M; Silvestro P; Villari P; Pergola M
    Clin Ter; 1989 Nov; 131(3):177-82. PubMed ID: 2533029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of clindamycin versus clindamycin plus tobramycin in the treatment of acute pelvic inflammatory disease.
    Gall SA; Constantine L
    Obstet Gynecol; 1990 Feb; 75(2):282-6. PubMed ID: 2405323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose tobramycin combined with clindamycin or lincomycin in the treatment of septic peritonitis and intraabdominal sepsis.
    Muth L; Edén T
    Acta Chir Scand; 1981; 147(5):339-46. PubMed ID: 7324760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia.
    Schentag JJ; Vari AJ; Winslade NE; Swanson DJ; Smith IL; Simons GW; Vigano A
    Am J Med; 1985 Feb; 78(2A):34-41. PubMed ID: 3881947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal surgery: short-term prophylaxis with aztreonam plus clindamycin versus gentamicin plus clindamycin.
    Puleo S; Sammartino R; Blandino G; Tempera G; Scilletta B; Rodolico G
    J Chemother; 1989 Jul; 1(4 Suppl):1008-9. PubMed ID: 16312746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.